Clinical and Histological Healing of Surgical Wounds Treated with Mitomycin C

Laryngoscope

Volumn 114, Issue 1, 2004, Pages 148-152

  De Andrade Quintanilha Ribeiro, Fernando ^a   Guaraldo, Lusiele ^a   De Pádua Borges, Janaina ^a   Silva Zacchi, Flávia Fernanades ^a   Eckley, Claudia A ^a,b  

^a Santa Casa School of Medicine   (Brazil)

^b Apartment 82 ^*  (Brazil)

Author keywords

Fibroblast inhibition; Mitomycin C; Surgical wound healing

Indexed keywords

MITOMYCIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FIBROGENESIS; FIBROSIS; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR FORMATION; SURGICAL WOUND; WOUND HEALING IMPAIRMENT;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; FIBROSIS; MALE; MITOMYCIN; RATS; RATS, WISTAR; SKIN; WOUND HEALING;

EID: 0942297878     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200401000-00027     Document Type: Article

References (25)

1. Supe SS, Supe SJ, Rao SM, Deka AC, Deka BC. Treatment of keloids by 90SR-90Y beta-rays. Strahlenther Onkol 1991;167:397-402.
2. Darzi MA, Chowdri NA, Kaul SK, Khan M. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 1992;45:374-9.
3. Manuskiatti W, Fitzpatrick RE. Treatment response of keloid and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp pumped pulsed-dye laser treatments. Arch Dermatol 2002;138:1149-1155.
4. Fitzpatrick Re. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999;25:224-232.
5. Chowdri NA, Masarat M, Mattoo A. Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy. Aust N Z J Surg 1999;69:655-659.
6. Alster T. Laser scar revision: comparison study of 585-nm pulsed-dye laser with and without intralesional corticosteroids. Dermatol Surg 2002;21:25-29.
7. Gray SD, Tritle N, Li W. The effect of mitomycin on extracellular matrix proteins in a rat wound model. Laryngoscope 2003;113:237-242.
8. Miyamura S, Shigeno N, Matsui S, Wakaki S, Uzu K. The biological studies on mitomycin, I: antibacterial activities of mitomycin derivatives. J Antibiot 1967;20:72-76.
9. Oboshi S, Matsui M, Ishii S, Masago N, Wakaki S. Antitumor studies in mitomycin and derivatives, II: effect on solid tumor of sarcoma-180. Gann 1967;58:315-321.
10. Bradner WT. Mitomycin C: a clinical update. Cancer Treat Rev 2001;27:35-50.
11. Crooke ST, Bradner WT. Mitomycin C: a review. Cancer Treat Rev 1976;3:121-139.
12. Bruijn EA, Sleeboom HP, van Helsdinger PJRO, van Oosterom AT, Tjaden UR, Maes RAA. Pharmacodynamics and pharmacokinetics of intravesical Mitomycin C upon different dwelling times. Int J Cancer 1992;51:359-364.
13. Hu D, Sires BS, Tong DC, Royack GA, Oda D. Effect of brief exposure to mitomycin C on cultured human nasal mucosa fibroblasts. Ophthalm Plast Reconstr Surg 2000;16:119-125.
14. Ingrams DR, Volk MS, Biesman BS, et al. Sinus surgery: does mitomycin-C reduce stenosis? Laryngoscope 1998;108:883-886.
15. Spector JE, Werkhaven JA, Spector NC, et al. Preservation of function and histologic appearance in the injured glottis with topical mitomycin C. Laryngoscope 1999;109:1125-1129.
16. Garrett CG, Soto J, Riddick J, Billante CR, Reinisch L. Effect of mitomycin-C on vocal fold healing in a canine model. Ann Otol Rhinol Laryngol 2001;110:25-30.
17. Rahbar R, Shapshay SM, Healy GB. Mitomycin: effects on laryngeal and tracheal stenosis, benefits, and complications. Ann Otol Rhinol Laryngol 2001;110:1-6.
18. Coppit G, Perkins J, Munaretto J, Nielsen R, McKinney L, Ulnick K. The effects of mitomycin-C and stenting on airway wound healing after laryngotracheal reconstruction in a pig model. Int J Pediatr Otorhinolaryngol 2000;53:125-135.
19. Jassir D, Buchman CA, Gomez-Marin O. Safety and efficacy of topical mitomycin C in myringotomy patency. Otolaryngol Head Neck Surg 2001;124:368-373.
20. Estrem SA, Batra PS. Preventing myringotomy closure with topical Mitomycin C in rats. Otolaryngol Head Neck Surg 1999;120:794-798.
21. Estrem SA, Van Leeuwen RN. Use of Mitomycin C for maintaining myringotomy patency. Otolaryngol Head Neck Surg 2000;122:8-10.
22. O'Reilly RC, Goldman SA, Widner SA, Cass SP. Creating a stable tympanic membrane perforation using mitomycin C. Otolaryngol Head Neck Surg 2001;124:40-45.
23. Chung JH, Cosenza MJ, Rahbar R, Metson RB. Mitomycin for the prevention of adhesion formation after endoscopic sinus surgery: a randomized, controlled study. Otolaryngol Head Neck Surg 2002;126:468-474.
24. Yazawa Y, Suzuki M, Kitano H, Kitajima K. Intraoperative mitomycin -C in endolymphatic sac surgery for Ménière's disease: a pilot study. ORL J Otorhinolaryngol Relat Spec 1999;61:188-194.
25. Cubukcu A, Alponat A, Gonullu NN, Ozkan S, Ercin C. An experimental study evaluating the effect of Mitomycin C on the prevention of postoperative intra-abdominal adhesions. J Surg Res 2001;96:163-166.